DRSLTR

Correspondence Related to Draft Registration Statement

Monte Rosa Therapeutics, Inc. Filed 2021-05-21 Acc 0000950123-21-007251

Documents 1

DRSLTR Correspondence Related to Draft Registration Statement , filename1.htm

Around this filing

2021-05-25 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2021-05-21 DRSLTR Correspondence Related to Draft Registration Statement
2021-05-21 DRS/A Draft Registration Statement
2021-05-17 UPLOAD SEC-generated Letter

Link to a passage

External

SEC EDGAR (opens in new tab)